Carl Koschmann - Concepedia

Author

Carl Koschmann

Also Known As

Brian Van Tine, C Kallstrom, C Koschmann, C. Koschmann, Carl J Koschmann, Carl J. Koschmann, Carl Johannes Koschmann, Carl Koschmann, Carl Koschmann#, Haussler, David

478

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

University of Michigan Michigan Medicine University of California, San Francisco Children's National Seattle Children's Hospital

About

Carl Koschmann is an author at University of Michigan specializing in medicine, neuro-oncology, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	862
2	Health Sciences	5	5	171
3	Engineering	2	2	63
4	Biomedical Engineering	2	2	175
5	Social Sciences	1	1	22

Carl Koschmann

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma Carl Koschmann, Anda‐Alexandra Calinescu, Felipe J. Núñez, Science Translational Medicine	2016	297
IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response Felipe J. Núñez, Flor Mendez, Padma Kadiyala, Science Translational Medicine	2019	283
Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas Chan Chung, Stefan R. Sweha, Drew Pratt, Cancer Cell Neuro-oncologySomatic VariantTumor HeterogeneityEpigenomic ReprogramingCancer Genomics	2020	204
The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location Ilon Liu, Li Jiang, Erik Samuelsson, Nature Genetics	2022	173
Mechanisms of Glioma Formation: Iterative Perivascular Glioma Growth and Invasion Leads to Tumor Progression, VEGF-Independent Vascularization, and Resistance to Antiangiogenic Therapy Gregory J. Baker, Viveka Nand Yadav, Sébastien Motsch, Neoplasia Glioma FormationBrain Tumor InvasionPathologyBiological MicroenvironmentsBrain Tumor Growth	2014	154
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, Cancer Discovery	2023	130
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma Evan Cantor, Kyle Wierzbicki, Rohinton S. Tarapore, Neuro-Oncology	2022	108
Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance Carol Durno, Ayse B. Ercan, Vanessa Bianchi, Journal of Clinical Oncology	2021	95
Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas Justyna M. Przystal, Chiara Cosentino, Sridevi Yadavilli, Neuro-Oncology	2022	91
TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory Iker Ausejo‐Mauleon, Sara Labiano, Daniel de la Nava, Cancer Cell	2023	88

Page 1